肝细胞癌(HCC)对索拉非尼耐药相关机制的研究进展
胡倍源1(综述 )覃伟1 董琼珠2 钦伦秀1,2,3△(审校)
复旦学报(医学版) ›› 2018, Vol. 45 ›› Issue (6) : 884.
肝细胞癌(HCC)对索拉非尼耐药相关机制的研究进展
Progress in the mechanism studies of hepatocellular carcinoma (HCC) resistance to sorafenib treatment
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |